Latest Articles

Publication Date
Rapid Progression Following Fertility-Sparing Management of High-Grade Endometrial Carcinoma: A - Frontiers

Rapid Progression Following Fertility-Sparing Management of High-Grade Endometrial Carcinoma: A Frontiers

Published: July 14, 2025, 3:17 p.m.
The Immune Microenvironment in Endometrial Carcinoma: Mechanisms and - Frontiers

The Immune Microenvironment in Endometrial Carcinoma: Mechanisms and Frontiers

Published: June 27, 2025, 10:51 p.m.
ARNTL-mediated INO80-DHX15 axis reprograms the glycolytic metabolism and augments the progression of endometrial carcinoma - Nature

ARNTL-mediated INO80-DHX15 axis reprograms the glycolytic metabolism and augments the progression of endometrial carcinoma Nature

Published: June 20, 2025, 8:06 p.m.
Cyclin D2 --a potential biomarker in uterine corpus endometrial carcinoma through methylation chip and bioinformatic analysis - Frontiers

Cyclin D2 --a potential biomarker in uterine corpus endometrial carcinoma through methylation chip and bioinformatic analysis Frontiers

Published: June 19, 2025, 10:09 p.m.
Multi-Omics Analysis of the Anti-Cancer Effects of Curcumol in Endometrial Carcinoma - Frontiers

Multi-Omics Analysis of the Anti-Cancer Effects of Curcumol in Endometrial Carcinoma Frontiers

Published: June 13, 2025, 5:14 a.m.
Impact of the Microcystic, Elongated, and Fragmented (MELF) Invasion Pattern on prognosis in Endometrial Carcinoma: A Comprehensive Meta-Analysis - Frontiers

Impact of the Microcystic, Elongated, and Fragmented (MELF) Invasion Pattern on prognosis in Endometrial Carcinoma: A Comprehensive Meta-Analysis Frontiers

Published: June 3, 2025, 2:36 p.m.
Comprehensive analyses of telomerase component DKC1 and its association with clinical, molecular and immune landscapes in uterine corpus endometrial carcinoma - Frontiers

Comprehensive analyses of telomerase component DKC1 and its association with clinical, molecular and immune landscapes in uterine corpus endometrial carcinoma Frontiers

Published: May 12, 2025, 7:50 p.m.
Isolated Splenic Metastasis and Splenic Bed Recurrence From Endometrial Carcinoma: A Rare Case - Cureus

Isolated Splenic Metastasis and Splenic Bed Recurrence From Endometrial Carcinoma: A Rare Case Cureus

Published: May 6, 2025, 11:44 a.m.
MYB Proto-Oncogene Like 2 Identified as a Biomarker for Uterine Corpus Endometrial Carcinoma: evidence from Bioinformatics and Clinical Validation - Frontiers

MYB Proto-Oncogene Like 2 Identified as a Biomarker for Uterine Corpus Endometrial Carcinoma: evidence from Bioinformatics and Clinical Validation Frontiers

Published: April 23, 2025, 2:47 p.m.
The value of multi-sequence magnetic resonance imaging and whole-tumor apparent diffusion coefficient histogram analysis in differentiating p53 abnormal from non-p53 abnormal endometrial carcinoma - Frontiers

The value of multi-sequence magnetic resonance imaging and whole-tumor apparent diffusion coefficient histogram analysis in differentiating p53 abnormal from non-p53 abnormal endometrial carcinoma Frontiers

Published: April 15, 2025, 2:55 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!